GRP
TERN

Global Retirement Partners’s Terns Pharmaceuticals TERN Stock Holding History

Global Retirement Partners’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$40 Sell
1
-41
-98% -$947 ﹤0.01% 4188
2025
Q3 		$315 Hold
42
– – ﹤0.01% 3700
2025
Q2 		$157 Buy
+42
New +$131 ﹤0.01% 3692

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CLGM
Capitolis Liquid Global Markets New York $15.7B AUM 30.78% 1-Year Est. Return

Global Retirement Partners's TERN Position: Q4 2025 in Review

Global Retirement Partners reduced its Terns Pharmaceuticals (TERN) stake by 98% in Q4 2025, selling an estimated $947 and leaving 1 share worth $40. The position accounts for ﹤0.01% of the portfolio, ranked #4188.

Global Retirement Partners first reported a position in TERN in Q2 2025 and has held it in 3 quarters since. The position peaked at $315 in Q3 2025. 248 funds tracked by Wall St. Rank hold TERN as of Q4 2025.

  • Global Retirement Partners held 1 share of Terns Pharmaceuticals worth $40 as of Q4 2025.
  • Global Retirement Partners sold 41 Terns Pharmaceuticals shares in Q4 2025, an estimated $947.
  • Terns Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #4188 holding.
  • Global Retirement Partners first reported a position in Terns Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • Global Retirement Partners's Terns Pharmaceuticals position peaked at $315 in Q3 2025.
  • 248 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.